Supplementary Table S1 from Pembrolizumab and Cabozantinib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Long-term Survival Update with a Biomarker Analysis
Year: 2024
Type: supplementary-materials
Abstract: Supplementary Table S1. Study representativeness.
Authors: Nabil F. Saba, Ritu Chaudhary, Kedar Kirtane, Angelo Marra, Asari Ekpenyong, Ashley McCook-Veal, Nicole C. Schmitt, Jennifer H. Gross, Mihir R. Patel, Jill Remick, James E. Bates, Mark W. McDonald, Soumon F. Rudra, William A. Stokes, Maria Biernacki, Xiaofei Song, Robbert J.C. Slebos, Yuan Liu, Conor E. Steuer, Dong M. Shin, Yong Teng, Christine H. Chung
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4403437205